Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): Epidemiology and pathogenesis

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue TOPIC T3, 2000, Pages 15-27

  Schulz, T F ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; ONCOVIRINAE; VIRUS GENOME; VIRUS TRANSMISSION;

EID: 0034038453     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.suppl_4.15     Document Type: Conference Paper

References (129)

1. Roth, W. K., Brandstetter, H. & Stürzl, M. (1992). Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 6, 895-913.
2. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. at al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-9.
3. Olsen, S. J. & Moore, P. S. (1998). Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) and the etiology of KS. In Molecular Immunology of Herpesviruses, (Friedman, H., Medveczky, P. & Bendinelli, M., Eds), pp. 115-147. Plenum, New York.
4. Schulz, T. F. (1998). Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). Journal of General Virology 79, 1573-91.
5. Boshoff, C. & Weiss, R. A. (1998). Kaposi's sarcoma-associated herpesvirus. Advances in Cancer Research 75, 57-86.
6. Schulz, T. F. (1999). Epidemiology of Kaposi's sarcoma-associated herpesvirus human herpesvirus 8. Advances in Cancer Research 76, 121-60.
7. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332, 1186-91.
8. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P. et al. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-80.
9. Rettig, M. B., Ma, H. J., Vescio, R. A., Põld, M., Schiller, G., Belson, D. et al. (1997). Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276, 1851-4.
10. Said, J. W., Rettig, M. R., Heppner, K., Vescio, R. A., Schiller, G., Ma, H. J. et al. (1997). Localisation of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patiets with multiple myeloma. Blood 90, 4278-82.
11. Chauhan, D., Bharti, A., Raje, N., Gustafson, E., Pinkus, G. S., Pinkus, J. L. et al. (1999). Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells. Blood 93, 1482-6.
12. Gao, S. J., Alsina, M., Deng, J. H., Harrison, C. R., Montalvo, E. A., Leach, C. T. et al. (1998). Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. Journal of Infectious Diseases 178, 846-9.
13. MacKenzie, J., Sheldon, J., Morgan, G., Cook, G., Schulz, T. F. & Jarrett, R. F. (1997). HHV-8 and multiple myeloma in the UK. Lancet 350, 1144-5.
14. Parravicini, C., Lauri, E., Baldini, L., Neri, A., Poli, F., Sirchia, G. et al. (1997). Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 278, 1969-73.
15. Whitby, D., Boshoff, C., Luppi, M. & Torelli, G. (1997). Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma. Science 278, 1971-2.
16. + selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genome. British Journal of Haematology 102, 1338-40.
17. Olsen, S. J., Tarte, K., Sherman, W., Hale, E. E., Weisse, M. T., Orazi, A. et al. (1998). Evidence against KSHV infection in the pathogenesis of multiple myeloma. Virus Research 57, 197-202.
18. Yi, Q., Ekman, M., Anton, D., Bergenbrant, S., Osterborg, A., Georgii-Hemming, P. et al. (1998). Blood dendritic cells from myeloma patients are not infected with Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8). Blood 92, 402-4.
19. Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N. et al. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proceedings of the National Academy of Sciences, USA 96, 4546-51.
20. Hjalgrim, H., Frisch, M. & Melbye, M. (1998). Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate. British Journal of Haematology 78, 419-20.
21. Tisdale, J. F., Stewart, A. K., Dickstein, B., Little, R. F., Dube, I., Cappe, D. et al. (1998). Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood 92, 2681-7.
22. Oksenhendler, E., Cazals-Hatem, D., Schulz, T. F., Barateau, V., Grollet, L., Sheldon, J. et al. (1998). Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. New England Journal of Medicine 338, 1585-90.
23. Parravicini, C., Olsen, S. J., Capra, M., Poli, F., Sirchia, G., Gao, S. J. et al. (1997). Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients. Blood 90, 2826-9.
24. Luppi, M., Barozzi, P., Schulz, T. F., Staskus, K., Trovato, R., Narni, F. et al. (2000). Non-malignant disease associated with HHV8-reactivation in autologous peripheral blood stem cell transplant patients in Italy. (Submitted.)
25. Whitby, D., Howard, M. R., Tenant-Flowers, M., Brink, N. S., Copas, A., Boshoff, C. et al. (1995). Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346, 799-802.
26. Ariyoshi, K., van der Loeff, M., Cook, P., Whitby, D., Corrah, T., Jaffar, S. et al. (1998). Kaposi's sarcoma in The Gambia, West Africa is less frequent in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. Journal of Human Virology 1, 193-9.
27. Bigoni, B., Dolcetti, R., de Lellis, L., Carbone, A., Boiocchi, M., Cassai, E. et al. (1996). Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. Journal of Infectious Diseases 173, 542-9.
28. Blum, L., Pellet, C., Agbalika, F., Blanchard, G., Morel, P., Calvo, F. et al. (1997). Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy. AIDS 11, 1653-5.
29. Gao, S. J., Kingsley, L., Hoover, D. R., Spira, T. J., Rinaldo, C. R., Saah, A. et al. (1996). Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. New England Journal of Medicine 335, 233-41.
30. Gao, S. J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J. et al. (1996). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nature Medicine 2, 925-8.
31. Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J. & Ganem, D. (1996). The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Medicine 2, 918-24.
32. Rainbow, L., Platt, G. M., Simpson, G. R., Sarid, R., Gao, S. J., Stoiber, H. et al. (1997). The 222 to 234 kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. Journal of Virology 71, 5915-21.
33. Kellam, P., Boshoff, C., Whitby, D., Matthews, S., Weiss, R. A. & Talbot, S. J. (1997). Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. Journal of Human Virology 1, 19-29.
34. Kedes, D. H., Lagunoff, M., Renne, R. & Ganem, D. (1997). Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. Journal of Clinical Investigation 100, 2606-10.
35. Simpson, G. R., Schulz, T. F., Whitby, D., Cook, P. M., Boshoff, C., Rainbow, L. et al. (1996). Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348, 1133-8.
36. Lin, S. F., Sun, R., Heston, L., Gradoville, L., Shedd, D., Haglund, K. et al. (1997). Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. Journal of Virology 71, 3069-76.
37. Chandran, B., Smith, M. S., Koelle, D. M., Corey, L., Horvat, R. & Goldstein, E. (1998). Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology 243, 208-17.
38. Raab, M. S., Albrecht, J. C., Birkmann, A., Yaguboglu, S., Lang, D., Fleckenstein, B. et al. (1998). The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. Journal of Virology 72, 6725-31.
39. Rabkin, C. S., Schulz, T. F., Whitby, D., Lennette, E. T., Magpantay, L. I., Chatlynne, L. et al. (1998). Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. Journal of Infectious Diseases 178, 304-9.
40. Zhu, L., Wang, R., Sweat, A., Goldstein, E., Horvat, R. & Chandran, B. (1999). Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1 A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 256, 381-92.
41. Lennette, E. T., Blackbourn, D. J. & Levy, J. A. (1996). Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348, 858-61.
42. Smith, M. S., Bloomer, C., Horvat, R., Goldstein, E., Casparian, J. M. & Chandran, B. (1997). Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. Journal of Infectious Diseases 176, 84-93.
43. Chatlynne, L. G., Lapps, W., Handy, M., Huang, Y. Q., Masood, R., Hamilton, A. S. et al. (1998). Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92, 53-8.
44. Whitby, D., Luppi, M., Barozzi, P., Boshoff, C., Weiss, R. A. & Torelli, G. (1998). Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. Journal of the National Cancer Institute 90, 395-7.
45. Calabrò, M. L., Sheldon, J., Favero, A., Simpson, G. R., Fiore, J. R., Gomes, E. et al. (1998). Seroprevalence of Kaposi's sarcoma-associated herpesvirus human herpesvirus 8 in several regions of Italy. Journal of Human Virology 1, 207-13.
46. Mayama, S., Cuevas, L. E., Sheldon, J., Omar, O. H., Smith, D. H., Okong, P. et al. (1998). Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. International Journal of Cancer 77, 817-20.
47. Bestetti, G., Renon, G., Mauclère, P., Ruffié, A., Mbopi Kéou, F. X., Eme, D. et al. (1998). High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 12, 541-3.
48. Bourboulia, D., Whitby, D., Boshoff, C., Newton, R., Beral, V., Carrara, H. et al. (1998). Serologic evidence for mother-to-child transmission of Kaposi's sarcoma-associated herpesvirus infection. Journal of the American Medical Association 280, 31-2.
49. Sitas, F., Carrara, H., Beral, V., Newton, R., Reeves, G., Bull, D. et al. (1999). Antibodies against human herpesvirus 8 in black South African patients with cancer. New England Journal of Medicine 340, 1863-71.
50. Gessain, A., Mauclere, P., van Beveren, M., Plancoulaine, S., Ayouba, A., Essame-Oyono, J. L. et al. (1999). Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. International Journal of Cancer 81, 189-92.
51. Beral, V., Peterman, T. A., Berkelman, R. L. & Jaffe, H. W. (1990). Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335, 123-8.
52. Renwick, N., Halaby, T., Weverling, G. J., Dukers, N. H., Simpson, G. R., Coutinho, R. A. et al. (1998). Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 12, 2481-8.
53. Martin, J. N., Ganem, D. E., Osmond, D. H., Page-Shafer, K. A., Macrae, D. & Kedes, D. H. (1998). Sexual transmission and the natural history of human herpesvirus 8 infection. New England Journal of Medicine 338, 948-54.
54. Melbye, M., Cook, P. M., Hjalgrim, H., Begtrup, K., Simpson, G. R., Biggar, R. J. et al. (1998). Risk factors for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV 8) seropositivity in a cohort of homosexual men, 1981-1996. International Journal of Cancer 77, 543-8.
55. Regamey, N., Tamm, M., Wernli, M., Witschi, A., Thiel, G., Cathomas, G. et al. (1998). Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. New England Journal of Medicine 339, 1358-63.
56. Farge, D., Lebbé, C., Marjanovic, Z., Tuppin, P., Mouquet, C., Peraldi, M. N. et al. (1999). Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Group Cooperatif de Transplantation d'lle de France (GCIF). Transplantation 67, 1236-42.
57. Qunibi, W., Al-Furayh, O., Almeshari, K., Lin, S. F., Sun, R., Heston, L. et al. (1998). Serologic association of human herpesvirus 8 with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 65, 583-5.
58. O'Brien, T. R., Kedes, D., Ganem, D., Macrae, D. R., Rosenberg, P. S., Molden, J. et al. (1999). Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma. Journal of Infectious Diseases 180, 1010-7.
59. Dukers, N. H., Renwick, N., Prins, M., Geskus, R. B., Schulz, T. F., Weverling, G.-J. et al. (2000). Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. American Journal of Epidemiology 151, 213-24.
60. Blackbourn, D. J. & Levy, J. A. (1997). Human herpesvirus 8 in semen and prostate. AIDS 11, 249-50.
61. Beral, V., Bull, D., Jaffe, H., Evans, B., Gill, N., Tillett, H. et al. (1991). Is risk of Kaposi's sarcoma in AIDS patients in Britain increased if sexual partners came from the United States or Africa? British Medical Journal 324, 624-5.
62. Kedes, D. H., Ganem, D., Ameli, N., Bacchetti, P. & Greenblatt, R. (1997). The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. Journal of the American Medical Association 277, 478-81.
63. Calabrò, M. L., Fiore, J. R., Favero, A., Lepera, A., Saracino, A., Angarano, G. et al. (1999). Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and -seronegative women. Journal of Infectious Diseases 179, 1534-7.
64. Angeloni, A., Heston, L., Uccini, S., Sirianni, M. C., Cottoni, F., Masala, M. V. et al. (1998). High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. Journal of Infectious Diseases 177, 1715-8.
65. Blauvelt, A., Sei, S., Cook, P. M., Schulz, T. F. & Jeang, K.-T. (1997). Human herpesvirus 8 infection occurs following adolescence in the United States. Journal of Infectious Diseases 176, 771-4.
66. Blackbourn, D. J., Ambroziak, J., Lennette, E., Adams, M., Ramachandran, B. & Levy, J. A. (1997). Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 349, 609-11.
67. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Van, M., Maddalena, D. et al. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proceedings of the National Academy of Sciences, USA 93, 14862-8.
68. Zong, J.-C., Ciufo, D. M., Alcendor, D. J., Wan, X., Nicholas, J., Browning, P. J. et al. (1999). High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human popultions. Journal of Virology 73, 4156-70.
69. Cook, P. M., Whitby, D., Calabro, M.-L, Luppi, M., Kakoola, D. N., Hjalgrim, H. et al. (1999). Variability and evolution of Kaposi's sarcoma-associated herpesvirus in Europe and Africa. AIDS 13, 1165-76.
70. Meng, Y. X., Spira, T. J., Bhat, G. J., Birch, C. J., Druce, J. D., Edlin, B. R. et al. (1999). Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology 15, 106-19.
71. Fouchard, N., Lacoste, V., Couppie, P., Develaux, M., Mauclere, P., Michel, P. et al. (2000). Detection and genetic polymorphism of human herpesvirus type 8 in endemic or epidemic Kaposi's sarcoma from West and Central Africa, and South America. International Journal of Cancer 85, 166-70.
72. Poole, L. J., Zong, J.-C., Ciufo, D. M., Alcendor, D. J., Cannon, J. S., Armbinder, R. et al. (1999). Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. Journal of Virology 73, 6646-60.
73. Glenn, M., Rainbow, L., Aurad, F., Davison, A. & Schulz, T. F. (1999). Identification of a spliced gene from Kaposi's sarcoma associated herpes virus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. Journal of Virology 73, 6953-63.
74. Choi, J.-K., Lee, B.-S., Shim, S. N., Li, M. & Jung, J. U. (2000). Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. Journal of Virology 74, 436-46.
75. Moore, P. S., Gao, S. J., Dominguez, G., Cesarman, E., Lungu, O., Knowles, D. M. et al. (1996). Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. Journal of Virology 70, 549-58.
76. Rose, T. M., Strand, K. B., Schultz, E. R., Schaefer, G., Rankin, G. W., Thouless, M. E. et al. (1997). Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. Journal of Virology 71, 4138-44.
77. Desrosiers, R. C., Sasseville, V. G., Czajak, S. C., Zhang, X., Mansfield, K. G., Kaur, A. et al. (1997). A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. Journal of Virology 71, 9764-9.
78. Greensill, J., Sheldon, J., Renwick, N., Beer, B., Norley, S., Goudsmit, J. et al. (2000). Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? Journal of Virology 74, 1572-7.
79. Searles, R. P., Bergquam, E. P., Axthelm, M. K. & ong, S. W. (1999). Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Journal of Virology 73, 3040-53.
80. Boshoff, C., Schulz, T. F., Kennedy, M. M., Graham, A. K., Fisher, C., Thomas, A. et al. (1995). Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Medicine 1, 1274-8.
81. Staskus, K. A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R. et al. (1997). Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. Journal of Virology 71, 715-9.
82. Davis, M. A., Stürzl, M. A., Blasig, C., Schreier, A., Guo, H. G., Reitz, M. et al. (1997). Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. Journal of the National Cancer Institute 89, 1868-74.
83. Foreman, K. E., Bacon, P. E., Hsi, E. D. & Nickoloff, B. J. (1997). In situ polymerase chain reaction-based localisation studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. Journal of Clinical Investigation 99, 2971-8.
84. Stürzl, M., Blasig, C., Schreier, A., Neipel, F., Hohenadl, C., Cornali, E. et al. (1997). Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. International Journal of Cancer 72, 68-71.
85. Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y. & Moore, P.S. (1998). Transcription mapping of the Kaposi's sarcoma-associated herpesvirus human herpesvirus 8 genome in body cavity-based lymphoma cell line (BC-1). Journal of Virology 72, 1005-12.
86. Decker, L L., Shankar, P., Khan, G., Freeman, R. B., Dezube, B. J., Lieberman, J. et al. (1996). The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. Journal of Experimental Medicine 184, 283-8.
87. Muralidhar, S., Pumfery, A. M., Hassani, M., Sadaie, M. R., Brady, J., Kishishita, M. et al. (1998). Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. Journal of Virology 72, 4980-8.
88. Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B. et al. (1999). A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 73, 5722-30.
89. Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden-Kent, D. et al. (1996). Cyclin encoded by KS herpesvirus. Nature 382, 410.
90. Swanton, C., Mann, D. J., Fleckenstein, B., Neipel, F., Peters, G. & Jones, N. (1997). Herpes viral cyclin/cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184-7.
91. Kip1 levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBO Journal 18, 654-63.
92. Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO Journal 18, 644-53.
93. Djerbi, M., Screpanti, V., Catrina, A. I., Bogen, B., Biberfeld, P. & Grandien, A. (1999). The inhibitor of death receptor signalling, FLICE-inhibitory protein defines a new class of tumor progression factors. Journal of Experimental Medicine 190, 1025-32.
94. Ballestas, M. E., Chatis, P. A. & Kaye, K. H. (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-4.
95. Szekely, L., Kiss, C., Mattsson, K., Kashuba, E., Pokrovskaja, K., Juhasz, A. et al. (1999). Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies. Journal of General Virology 90, 2889-900.
96. Friborg, J., Kong, W.-P., Hottiger, M. O. & Nabel, G. J. (1999). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-94.
97. Platt, G. M., Simpson, G. R., Mittnacht, S. & Schultz, T. F. (1999). Latent nuclear artigen of Kaposi's sarcoma-associated herpesvirus interacts with RINGS, a homolog of the Drosophila female sterile homeotic (fsh) gene. Journal of Virology 73, 9789-95.
98. Orenstein, J. M., Alkan, S., Blauvelt, A., Jeang, K.-T., Weinstein, M. D., Ganem, D. et al. (1997). Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11, F35-45.
99. Blasig, C., Zietz, C., Haar, B., Neipel, F., Esser, S., Brockmeyer, N. H. et al. (1997). Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. Journal of Virology 71, 7963-8.
100. Lee, H., Veazey, R., Williams, K., Li, M., Quo, J., Neipel, F. et al. (1998). Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Medicine 4, 435-40.
101. Lee, H., Quo, J., Li, M., Choi, J.-K., DeMaria, M., Rosenzweig, M. et al. (1998). Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Molecular and Cellular Biology 18, 5219-28.
102. Gao, S. J., Boshoff, C., Jayachandra, S., Weiss, R. A., Chang, Y. & Moore, P. S. (1997). KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979-85.
103. Zimring, J. C., Goodbourn, S. & Offermann, M. K. (1998). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. Journal of Virology 72, 701-7.
104. Jayachandra, S., Low, K. G., Thlick, A.-E., Yu, J., Ling, P. D., Chang, Y. et al. (1999). Three unrelated viral transforming proteins (vIRF, EBNA2, and E1a) induce the MYC oncogene through the interferon-responsive PRF element by suing different transcriptioncoadaptors. Proceedings of the National Academy of Sciences, USA 96, 11566-71.
105. Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S. et al. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-99.
106. Boshoff, C., Endo, Y., Collins, P. D., Takeuchi, Y., Reeves, J. D., Schweickart, V. L. et al. (1997). Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-4.
107. Flore, O., Rafii, S., Ely, S., O'Leary, J. J., Hyjek, E. M. & Cesarman, E. (1998). Transformation of primary endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394, 588-92.
108. Rabkin, C. S., Janz, S., Lash, A., Coleman, A. E., Musaba, E., Liotta, L. et al. (1997). Monoclonal origin of multicentric Kaposi's sarcoma lesions. New England Journal of Medicine 336, 988-93.
109. Delabesse, E., Oksenhendler, E., Lebbé, C., Verola, O., Varet, B. & Turhan, A. G. (1997). Molecular analysis of clonality in Kaposi's sarcoma. Journal of Clinical Pathology 50, 664-8.
110. Gill, P., Tsai, Y., Rao, A. P. & Jones, A. P. (1997). Clonality in Kaposi's sarcoma. New England Journal of Medicine 337, 570-1.
111. Herndier, B. (1999). Cancer (or lack thereof) and viruses. Trends in Microbiology 7, 269-70.
112. Moore, P. S., Boshoff, C., Weiss, R. A. & Chang, Y. (1996). Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-44.
113. Molden, J., Chang, Y., You, Y., Moore, P. S. & Goldsmith, M. A. (1997). A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vlL-6) activates signaling through the shared gp130 receptor subunit. Journal of Biological Chemistry 272, 19625-31.
114. Neipel, F., Albrecht, J.-C., Ensser, A., Huang, Y.-Q., Li, J. J., Friedman-Kien, A. E. et al. (1997). Human herpesvirus 8 encodes a homolog of interleukin-6. Journal of Virology 71, 839-42.
115. Nicholas, J., Ruvolo, V. R., Burns, W. H., Sandford, G., Wan, X., Ciufo, D. et al. (1997). Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nature Medicine 3, 287-92.
116. Medveczky, M. M., Horvath, E., Lund, T. & Medveczky, P. G. (1997). In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 11, 1327-32.
117. Kedes, D. H. & Ganem, D. (1997). Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Journal of Clinical Investigation 99, 2082-6.
118. Neyts, J. & De Clercq, E. (1997). Antiviral drug susceptibility of human herpesvirus 8. Antimicrobial Agents and Chemotherapy 41, 2754-6.
119. Glesby, M. J., Hoover, D. R., Weng, S., Graham, N. M., Phair, J. P., Detels, R. et al. (1996). Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. Journal of Infectious Diseases 173, 1477-80.
120. Mocroft, A., Youle, M., Gazzard, B., Morcinek, J., Halai, R. & Phillips, A. N. (1996). Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 10, 1101-5.
121. loannidis, J. P., Collier, A. C., Cooper, D. A., Corey, L., Fiddian, A. P., Gazzard, B. G. et al. (1998). Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. Journal of Infectious Diseases 178, 349-59.
122. Morfeldt, L. & Torssander, J. (1994). Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scandinavian Journal of Infectious Diseases 26, 753-4.
123. Boivin, G., Gaudreau, A., Toma, E., Lalonde, R., Routy, J. P., Murray, G. et al. (1999). Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Antimicrobial Agents and Chemotherapy 43, 377-80.
124. Humphrey, R. W., O'Brien, T. R., Newcomb, F. M., Nishihara, H., Wyvill, K. M., Ramos, G. A. et al. (1996). Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood 88, 297-301.
125. Low, P., Neipel, F., Rascu, A., Steininger, H., Manger, B., Fleckenstein, B. et al. (1998). Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8-associated hemophagocytic syndrome. European Journal of Medical Research 3, 461-4.
126. Sun, R., Lin, S.-F., Staskus, K., Gradoville, L., Grogan, E., Haase, A. et al. (1999). Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. Journal of Virology 73, 2232-42.
127. Sun, R., Lin, S.-F., Gradoville, L., Yuan, Y., Zhu, F. & Miller, G. (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proceedings of the National Academy of Sciences, USA 85, 10866-71.
128. Zhu, F. X., Cusano, T. & Yuan, Y. (1999). Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 73, 5556-67.
129. Lukac, D. M., Renne, R., Kirshner, J. R. & Ganem, D. (1998). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF50 transactivator, a homolog of the EBV R protein. Virology 252, 304-12.